These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


724 related items for PubMed ID: 22441774

  • 1. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D.
    Circ Heart Fail; 2012 May 01; 5(3):322-30. PubMed ID: 22441774
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A.
    Circulation; 2016 Apr 26; 133(17):1637-44. PubMed ID: 27029350
    [Abstract] [Full Text] [Related]

  • 7. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators.
    Am Heart J; 2005 Apr 26; 149(4):645-9. PubMed ID: 15990747
    [Abstract] [Full Text] [Related]

  • 8. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators.
    Lancet; 2015 Jun 13; 385(9985):2363-70. PubMed ID: 25749644
    [Abstract] [Full Text] [Related]

  • 9. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct 13; 144(4):597-607. PubMed ID: 12360154
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure).
    Caldentey G, Khairy P, Roy D, Leduc H, Talajic M, Racine N, White M, O'Meara E, Guertin MC, Rouleau JL, Ducharme A.
    JACC Heart Fail; 2014 Feb 13; 2(1):15-23. PubMed ID: 24622114
    [Abstract] [Full Text] [Related]

  • 11. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D, AF-CHF investigators.
    Circ Heart Fail; 2012 Sep 01; 5(5):586-93. PubMed ID: 22798522
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
    Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD, Beta-Blockers in Heart Failure Collaborative Group.
    Lancet; 2014 Dec 20; 384(9961):2235-43. PubMed ID: 25193873
    [Abstract] [Full Text] [Related]

  • 13. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, AFFIRM Investigators.
    Am Heart J; 2005 Apr 20; 149(4):657-63. PubMed ID: 15990749
    [Abstract] [Full Text] [Related]

  • 14. Is heart rate important for patients with heart failure in atrial fibrillation?
    Cullington D, Goode KM, Zhang J, Cleland JG, Clark AL.
    JACC Heart Fail; 2014 Jun 20; 2(3):213-20. PubMed ID: 24952686
    [Abstract] [Full Text] [Related]

  • 15. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ.
    N Engl J Med; 1999 Sep 16; 341(12):857-65. PubMed ID: 10486417
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction.
    Moretti M, Fabris E, Morosin M, Merlo M, Barbati G, Pinamonti B, Gatti G, Pappalardo A, Sinagra G.
    Am J Cardiol; 2014 Dec 01; 114(11):1722-8. PubMed ID: 25316349
    [Abstract] [Full Text] [Related]

  • 17. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ, Chung MJ, Gheorghiade M, Pang PS, Kwasny MJ, Ambrosy AP, Vaduganathan M, O'Connor CM, Swedberg K, Zannad F, Konstam MA, Maggioni AP.
    Am Heart J; 2012 Dec 01; 164(6):884-92.e2. PubMed ID: 23194489
    [Abstract] [Full Text] [Related]

  • 18. Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
    Henrard V, Ducharme A, Khairy P, Gisbert A, Roy D, Levesque S, Talajic M, Thibault B, Racine N, White M, Guerra PG, Tardif JC, AF-CHF investigators.
    Int J Cardiol; 2013 May 25; 165(3):430-6. PubMed ID: 21917326
    [Abstract] [Full Text] [Related]

  • 19. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I, John Camm A.
    Europace; 2004 Sep 25; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [Abstract] [Full Text] [Related]

  • 20. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO, Marzouka GR, Rathod AD, Patel NJ, Myerburg RJ, Mitrani RD.
    Am J Cardiol; 2013 Jun 15; 111(12):1759-63. PubMed ID: 23540545
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.